In8Bio (INAB) Accounts Payables (2020 - 2026)

In8Bio has disclosed Accounts Payables across 7 years of filings, most recently posting $444000.0 for Q2 2026.

• In Q2 2026, Accounts Payables rose 17.15% year-over-year to $444000.0; the TTM figure through Jun 2026 stood at $444000.0 (up 17.15% YoY), while the FY2025 annual figure was $309000.0, down 20.57% from the prior year.
• Accounts Payables came in at $444000.0 for Q2 2026 at In8Bio, down from $449000.0 in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $2.1 million in Q4 2022 to a low of $204000.0 in Q3 2025.
• Average Accounts Payables over 5 years is $770352.9, with a median of $585000.0 recorded in 2023.
• Year-over-year, Accounts Payables soared 429.37% in 2022 and sank 82.06% in 2025.
• Over 5 years, Accounts Payables stood at $2.1 million in 2022, then plunged by 55.81% to $924000.0 in 2023, then slumped by 57.9% to $389000.0 in 2024, then dropped by 20.57% to $309000.0 in 2025, then soared by 43.69% to $444000.0 in 2026.
• Per Business Quant data, the three most recent Accounts Payables figures were $444000.0 in Q2 2026, $449000.0 in Q1 2026, and $309000.0 in Q4 2025.